A Novel Promazine Derivative Shows High in vitro and in vivo Antimicrobial Activity Against Staphylococcus aureus

MLA

Nadia S Jørgensen, et al. “A Novel Promazine Derivative Shows High in Vitro and in Vivo Antimicrobial Activity Against Staphylococcus Aureus.” Frontiers in Microbiology, vol. 11, Sept. 2020. EBSCOhost, https://doi.org/10.3389/fmicb.2020.560798.

APA

Nadia S Jørgensen, Søren W Svenningsen, Troels Ronco, Iben Holmer, Jørn B. Christensen, Ehsan Sheikhsamani, Rikke Heidemann Olsen, Anders Permin, & Sofie Kromann. (2020). A Novel Promazine Derivative Shows High in vitro and in vivo Antimicrobial Activity Against Staphylococcus aureus. Frontiers in Microbiology, 11. https://doi.org/10.3389/fmicb.2020.560798

Chicago

Nadia S Jørgensen, Søren W Svenningsen, Troels Ronco, Iben Holmer, Jørn B. Christensen, Ehsan Sheikhsamani, Rikke Heidemann Olsen, Anders Permin, and Sofie Kromann. 2020. “A Novel Promazine Derivative Shows High in Vitro and in Vivo Antimicrobial Activity Against Staphylococcus Aureus.” Frontiers in Microbiology 11 (September). doi:10.3389/fmicb.2020.560798.